CymaBay Therapeutics, Inc is a biotechnology business based in the US. CymaBay Therapeutics shares (CBAY) are listed on the NASDAQ and all prices are listed in US Dollars. CymaBay Therapeutics employs 41 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in CymaBay Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CBAY – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
CymaBay Therapeutics stock price (NASDAQ: CBAY)Use our graph to track the performance of CBAY stocks over time.
CymaBay Therapeutics shares at a glance
|Latest market close||$4.23|
|52-week range||$3.42 - $9.06|
|50-day moving average||$4.49|
|200-day moving average||$4.84|
|Wall St. target price||$11.64|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.38|
Buy CymaBay Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy CymaBay Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
CymaBay Therapeutics price performance over time
|1 week (2021-07-17)||N/A|
|1 month (2021-06-28)||-7.03%|
|3 months (2021-04-28)||-9.42%|
|6 months (2021-01-24)||N/A|
|1 year (2020-07-24)||N/A|
|2 years (2019-07-24)||N/A|
|3 years (2018-07-24)||N/A|
|5 years (2016-07-24)||N/A|
CymaBay Therapeutics financials
|Gross profit TTM||$-35,882,000|
|Return on assets TTM||-21.9%|
|Return on equity TTM||-36.64%|
|Market capitalisation||$289.8 million|
TTM: trailing 12 months
Shorting CymaBay Therapeutics shares
There are currently 7.6 million CymaBay Therapeutics shares held short by investors – that's known as CymaBay Therapeutics's "short interest". This figure is 5.7% down from 8.1 million last month.
There are a few different ways that this level of interest in shorting CymaBay Therapeutics shares can be evaluated.
CymaBay Therapeutics's "short interest ratio" (SIR)
CymaBay Therapeutics's "short interest ratio" (SIR) is the quantity of CymaBay Therapeutics shares currently shorted divided by the average quantity of CymaBay Therapeutics shares traded daily (recently around 837465.82694414). CymaBay Therapeutics's SIR currently stands at 9.13. In other words for every 100,000 CymaBay Therapeutics shares traded daily on the market, roughly 9130 shares are currently held short.
However CymaBay Therapeutics's short interest can also be evaluated against the total number of CymaBay Therapeutics shares, or, against the total number of tradable CymaBay Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CymaBay Therapeutics's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 CymaBay Therapeutics shares in existence, roughly 110 shares are currently held short) or 0.1629% of the tradable shares (for every 100,000 tradable CymaBay Therapeutics shares, roughly 163 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against CymaBay Therapeutics.
Find out more about how you can short CymaBay Therapeutics stock.
CymaBay Therapeutics share dividends
We're not expecting CymaBay Therapeutics to pay a dividend over the next 12 months.
CymaBay Therapeutics share price volatility
Over the last 12 months, CymaBay Therapeutics's shares have ranged in value from as little as $3.417 up to $9.06. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CymaBay Therapeutics's is 1.1795. This would suggest that CymaBay Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
CymaBay Therapeutics overview
CymaBay Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta, which has completed Phase II clinical study for the treatments of primary biliary cholangitis, as well as patients with nonalcoholic steatohepatitis. The company also develops MBX-2982, which is in Phase 2a clinical study for the disease/condition of hypoglycemia in type 1 diabetics; and CB-0406, which is in Phase I clinical trial for the inflammation disease/condition. Its preclinical stage product candidate is CB-001, a G protein-coupled receptor for omega-3 fatty acids, such as docosahexaenoic acid for the treatment of gut/liver disease. It has a license agreement with DiaTex, Inc. to develop and commercialize therapeutic products comprising halofenate and its enantiomers, derivatives, and analogs for the treatment of diseases; and holds a worldwide license from Janssen Pharmaceuticals, Inc.
Stocks similar to CymaBay Therapeutics
CymaBay Therapeutics in the news
Were Hedge Funds Right About CymaBay Therapeutics Inc (CBAY)?
New Strong Sell Stocks for July 20th
Is CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Popular Amongst Institutions?
Frequently asked questionsWhat percentage of CymaBay Therapeutics is owned by insiders or institutions?
Currently 0.398% of CymaBay Therapeutics shares are held by insiders and 81.971% by institutions. How many people work for CymaBay Therapeutics?
Latest data suggests 41 work at CymaBay Therapeutics. When does the fiscal year end for CymaBay Therapeutics?
CymaBay Therapeutics's fiscal year ends in December. Where is CymaBay Therapeutics based?
CymaBay Therapeutics's address is: 7575 Gateway Boulevard, Newark, CA, United States, 94560 What is CymaBay Therapeutics's ISIN number?
CymaBay Therapeutics's international securities identification number is: US23257D1037 What is CymaBay Therapeutics's CUSIP number?
CymaBay Therapeutics's Committee on Uniform Securities Identification Procedures number is: 23257D103
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert